IMUNOLOGIA CLÍNICA

ABBRANCHIO, M.P., Boeynaems, J.M. Barnard, E.A. Boyer, J.L., Kennedy,

C., Miras-Portugal, M.T., King, B.F., Gachet, C., Jacobson, K.A., Weisman,

G.A.and Burnstock, G. 2003.Characterization of the UDP-glucose receptor (renamed here the P2Y14 receptor) adds diversity to the P2Y receptor

family.Trends.Pharmacol.Sci. 24, 52-55.

ABBRANCHIO, M.P., Burnstock, G., Boeynaems, J.M., Barnard, E.A Boyer,

J.L., Kennedy, C., Knight, G.E., Fumagalli, M.., Gachet, C., Jacobson, K.A. and

Weisman, G.A. 2006. International Union of Pharmacology LVII: update on P2Y

G protein coupled nucleotide receptors : from molecular mechanisms

pathophysiology to therapy.Pharmacol. Rev. 58, 281-341.

AFONSO, L.C.C. and Scott, P. 1993. Imunne responses associated with

susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Imunn.

:2952-2959.

ALEXANDER, J. and K. Vickerman. 1975. Fusion of host cell secondary

lysosomes with the parasitophorous vacuole of Leishmania mexicana

macrophages. J. Protozool. 22-502.

ALMEIDA-AMARAL, E.E., R.Belmont-Firpo, M.A.Vannier-Santos, and

Meyer-Fernandes, J.R. 2006. Leishmania amazonensis: characterization of an

ecto-phosphatase activity. Exp. Parasitol. 114(4):334-40. ASAI, T. Miura, S.

Sibley, L.D.1995. Okabayashi, H. Takeuchi, T. Biochemical and molecular

characterization of nucleoside triphosphate hidrolase isozymes from the prasite

protozoan Toxoplasma gondii. J. Biol.Chem. 270: 1191-7.

BACELLAR O, Brodskyn C, Guerreiro J, Barral-Netto M, Costa CH, Coffman

RL, Johnson WD, Carvalho EM.1996.Interleukin-12 restores interferon-gamma

production and cytotoxic responses in visceral leishmaniasis. Journal of

Infectious Diseases 173: 1515- 1518. BACELLAR O, D’Oliveira A, Jr.,

Jeronimo S, Carvalho EM. 2000. IL-10 and IL-12 are the main regulatory

cytokines in visceral leishmaniasis. Cytokine. 12: 1228-1231.

BAKALARA, N., Seyfang, A., Davis, C., and Baltz, T.1995. Characterization of

a Life-Cycle-Stage Regulted Membrane Protein Tyrosine Phosphatase in

Trypanosoma brucei. Eur.J.Biochem.234, 871–877. BARGANHOL, E.,

S.K.A.Tamajasuku, A. Bernardi, M.R. Wink, and Battastini A.M.O, 2007.Ecto5’-nucleotidase/CD73 inibhition by quercetin in the human U138MG glioma cell

line. Bioch. Biophys. Acta.1770: 1352-1359.

BARRAL, A., M.Barral-Netto, E.C.Young, C.E.Brownell, D.R.Twardzik, and

S.G.Reed. 1993. Tranforming growth factor β as a virulence mechanism for

Leishmania brasiliensis. Proc.Natl.Acad.Sci. 90(8):3442-3446.

BERREDO-PINHO, M., C.E.Peres-Sampaio, P.P.Chrispim, R.Belmont-Firpo,

A.P.Lemos, A.Martiny, M.A.Vannier-Santos, and J.R.Meyer-Fernandes. 2001. A

Mg-dependent ecto-atpases in Leishmania amazonensis and its possible role in

adenosine acquisition and virulence. Arch.Biochem.Biophys. 391:16-24

BERTHOLET, S., A.Debrabant, F.Afrin, E.Caler, S.Mendez, K.S.Tabbara,

Y.Belkaide, and D.L.Sacks. 2005. Antigen requeriments for Efficient Priming of

CD8+ T cells by Leishmania major- Dendritic Cells. Infect.Immun. 73(8):4714-

BETTINI, S., Gradoni, L., 1986. Canine leishmaniasis in the Mediterranean area

and its implications for human leishmaniasis. Insect. Sci. Appl. 7, 241–245.

BISSAGIO, D.F., Peres-Sampaio, Meyer-Fernades, J.R., and Souto-Padron, T.

Ecto-ATPase activity on the surface of the Trypanosoma cruzi and its

possible role in the parasite-host cell interaction. Parasitol.Res. 91, 273-282.

BOGDAN C, Rollinghoff M, and Diefenbach A: The role of nitric oxide in

innate immunity. Immunol Rev 2000, 173:17-26. BORGES, F.P., B.Gottardi,

C.Stuepp, A.B. Larré, T. Tasca, G.A.De Carli, and Bonan C.D. 2007.

Caracterization of an ecto-5’- nucleotidase (EC 3.1.3.5.) activity in intact

trophozoites of Trichomonas gallinae.Veter. Pasitol. 143:106-111.

BRINTTINGHAM, A, and Mosser, D.M. 2006. Exploitation of the complement

system by Leishmania promastigotes. Parasitol Today. 12. 444-447 BRYANT. S.

M., L. A. Guthrie, M. J. Pabst. and R. B. Johnston, Jr.1986. Macrophage

membrane proteins: possible role in the regulation of priming for enhanced

respiratory burst activity. Cell. Immunol. 45-53.

BURNSTOCK G. 2007. Purine and Pyrimidine receptors. Cell.Mol.Life.Sci.64,

-1483. CABRAL, M., O’grady, J.E., Gomes, S., Sousa, J.C., Thompson, H.,

Alexander, J., 1998. The immunology of canine leishmaniasis: strong evidence

for a developing disease spectrum from asymptomatic dogs. Vet. Immunol.

Immunopathol. 76, 173–180.

CARVALHO E.M, Bacellar O.A, Reed S, Barral A, Rocha H. 1988.Visceral

leishmaniasis: a disease associated with inability of lymphocytes to activate

macrophages to kill leishmania. Brazilian Journal of Medical Biological

Research. 21: 85-92.

CHANG, K. P. 1981. Leishmania donouanl-macrophage binding mediated by

surface glycoproteins/antigens. Mol. Biochem. Parasitol.4-67.

CHANG, K.-P., D. Fong, and R. S. Bray. 1985. Biology of Leishmania and

leishmaniasis, Chang and R. S. Bray (ed.), Leishmaniasis. Elsevier, London. p. 1-

In K.-P.

CHANG. K. P., and D. M. Dwyer. 1976. Multiplication of a human parasite

(Leishmania donovani) in the phagolysosomes of hamster macrophages in vitro.

Science 193:678.

CHILDS, G.E., L.K.Lightner, L.Mackinney, M.G.Groves, E.E.Prices, and

L.D.Hendricks. 1984. Inbred mice as model hosts for cutaneous leishmaniasis. I.

Resistance and susceptibility to infection with Leishmania amazonensis, L.

mexicana, and L. aethiopica. Ann.Trop.Med.Parasitol. 78:25-34.

COHN, C.S, Gottlieb M. 1997.The acquisition of purines by Trypanosomatids.

Parasitol Today;13:231 –5. COIMBRA, E.S., S.C.Gonçalves-da-Costa., S.CorteReal, F.G.De Freitas, A.C.Durão, C.S Souza, M.I.Silva-Santos, e E.G

Vasconcelos. 2002. Characterization and cytochemical localization of an

diphosphohydrolase from Leishmania amazonensis promastigotes. Parasitol.

:137-143.

COOL, D.E., Blum, J.J., 1993. Protein tyrosine phosphatase activity in

Leishmania donovani. Molecular and Cellular Biochemistry (127/128),143–149.

DI VIRGILIO, F.2007. Purinergic singnalling in the immune system . A brief

update. Purinergic singnalling. 3,1-3

DING, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen

intermediates and reactive oxygen intermediates from mouse peritoneal

macrophages: comparison of activating cytokines and evidence for independent

production. J.Immunol. 141:2407–2412.

DING A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S.

Macrophage deactivating factor and transforming growth factors-beta 1-

beta 2 and-beta 3 inhibit induction of macrophage nitrogen oxide synthesis by

IFN-gamma. Journal of Immunology 145: 940-944. DE ALMEIDA M.C,

Cardoso S.A, Barral-Netto M. 2003.Leishmania (Leishmania) chagasi infection

alters the expression of cell adhesion and costimulatory molecules on human

monocyte and macrophage. International Journal of Parasitology 33: 153-162.

DUARTE, M.I.S. & Cobertt, C.E.P. 1994. Patologia das principais doenças

tropicais no Brasil; leishmaniose visceral. In: Brasileiro Filho G, Pitella Jeh,

Pereira Fel, Bambirra Ea & Barbosa Aja. Bogliolo Patologia 5 ed. Rio de

Janeiro: Guanabara Koogan,. Cap. 33, 1151- 1152.

DUTRA, P.M.L., Rodrigues, C.O., Jesus, J.B., Lopes, A.H.C.S., Souto-Padrón,

T., Meyer-Fernandes, J.R., 1998. A novel Ecto-phosphatase activity of

Herpetomonas muscarum muscarum inhibited by plateletactivation factor.

Biochemical and Biophysical Research Communications. 253, 164–169.

EVANS, T.G., L. Thai, D.L. Granger, and J.B. Hibbs, Jr. 1993.Effect of in vivo

inhibition of nitric oxide production in murine leishmaniasis. J. Immunol.

:907-912. FERRARI, D., Pizzirani, C., Adinolfi, E., Lemoli, R.M., Idzko, M.,

Panther, E. and Di Virgilio. 2006. The P2X7 receptor: a key palyer in IL-1

processing and release. J. Immmunol. 35, 527-537.

FERRARO, R.B., Souza, J.L., Cunha, R.D.C., and Meyer-Fernandes,

J.R.,2004.Characterization of an ecto-phosphatase activity in malpighian

tubulesof hematophagous bug Rhodnius prolixus. Archives of Insect

Biochemistry and Physiology.57, 40–49.

FRETES, R.E., Paglini, P., Fernadez A.R., Enders, J. and De Fabro, S.P. 1999.

Trypanosoma cruzi: increased 5’-nucleotidase activity associated with

disfunction of adrenergic receptors in acutely infection albino Swiss mice.

J.Parasitol. 85, 970-972.

FURUYA, T., Zhong, L., Meyer-Fernandes, J.R., Hong-Gang, L., Moreno,

S.N.J., and Docampo, R., 1998. Ecto-protein tyrosine phosphatase activity in

Trypanosoma cruzi infective stages. Molecular and Biochemical Parasitology.

, 339–348.

FUNDAÇÃO NACIONAL DE SAÚDE.2000. Guia de Doenças da Funadação

Nacional de Saúde. URL: http://www. funasa. gov.

br/guia_epi/htm/doenças/leishmaniose visceral.

GHALIB H.W, Piuvezam M.R, Skeiky Y.A, Siddig M, HashimF.A, el-Hassan

A.M, Russo DM, Reed SG. 1993.Interleukin 10 production correlates with

pathology in human Leishmania donovani infections. Journal of Clinical

Investigation. 92: 324-329.

GREEN, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Whishnok, and

S. R. Tannenbaum. 1984. Analysis of nitrate, nitrite and (15N) nitrate in

biological fluids. Analytical Biochemistry.126: 131–136.

GREEN, S.J., M.S. Meltzer, J.B. Hibbs, Jr., and C.A. Nacy. 1990.Activated

macrophages destroy intracellular Leishmania major amastigotes by an Larginine-dependent killing mechanism. J. ImmunoL 144:278.

GRIMALDI, G.Jr., and Tesh, B.R. 1993. Leishmaniases of the New World:

Current Concepts and Implications for Future Research. Am.Society for

Microbiology. 6:230-250

GHOSH, M., and Mukherjee, T. 2000. Stage-specific development of a novel

adenosine transporter in Leishmania donovani amastigotes.

Mol.Biochem.Parasitol. 108:93-99

GLEW, R.H., A.K. Saha, S. Das, and A.T. Remaley.1988. Biochemistry of the

Leishmania species.Microbiol Rev.52(4): 412–432.

GODING,J.W. and M.C.Howard. 1998. Ecto-enzymes of lymphoid cells.

Immunol.Rev. 161:5-10.

GOTTLIEB, M. and D.M. Dwyer.1982. Identification and partial

characterization of an extracellular acid phosphatase activity of Leishmania

donovani promastigotes. Mol Cell Biol.2(1): 76–81

GOTTLIEB, M. and Dwyer. D.M. 1983. Evidence for distinct 5’-and-3’-

nucleotidase activities in the surface membrane fraction of Leishmania donovani

promastigotes. Mol.Biochem.Parasitol. 7, 303-317. 71

HASKO, G., Kuhel, D.G., Chen, J.F., Schwarzchild, M.A., Deitch, E.A.,

Mabley, J.G., Marton, A. and Szabo, C.2000. Adenosine inhibitis IL-12 and

TNF-alpha production via adenosine A2A receptor-dependent and independent

mechanisms. FASEB.J.14, 2065- 2074.

HANDMAN, E. and Bullen, 2002. Interaction of Leishmania with the host

macrophages. Trends Parasitol. 18, 332-334.

HEINZEL, F. P.; Sadick, M. D.; Mutha, S. S.; and Locksley, R. M. 1991.

Production of interferon-gamma, interleukin-2, interleukin-4 and interleukin-10

by CD4+ lymphocytes in vivo during healing and progressive murine

leishmaniasis. Proceeding of the National Academy of Science of the United

States of American, v.88, p.7011-7015.

HEINZEL, E P., Sadick ,M. D. Holaday, B. J. Coffman, R. L. and Locksley, R.

M. 1989. Reciprocal expression of interferon-gamma or interleukin 4 during the

resolution or progression of murine leishmaniasis. J. Exp. Med.169.59.

HOWARD, J.G., Hale, C. and Chan Liew, W.L. 1980. Immunological regulation

of experimental cutaneos leishmaniasis. V. Characterization of effector and

specific suppressor T cells. J. Immunol. 128: 1917.

HUMPHREYS, B. D., & Dubyak, G. R.1998. Modulation of P2X7 nucleotide

receptor expression by pro-and anti-inflammatory stimuli in THP-1 monocytes.

J.Leukoc. Biol. 64(2), 265–273.

JACOBSON, K.A. and Gao, Z.G.2006.Adenosine receptors as therapeutic

targets. Nat.Dev.Drug.Discov.5, 247-264.

JANUSZ. M. J. K. F. Austen, and J. K. Czop. 1987. Lysosomal enzyme release

from human monocytesb y particulate activators is mediated by p-glucan

inhibitable receptors. J. Immunol. 138:3897.

JESUS, J.B., Podlyska, T.M., Lopes, A.H.C.S., Vannier-Santos, M.A., and

Meyer-Fernandes, J.R., 2002. Characterization of an ecto-phosphatase activity in

the human parasite Trichomonas vaginalis. Parasitology Research 88, 991–997.

JIAXIANG, J. J. Masterson, J. Sun, and L. Soong.2005. CD4+ CD25+

Regulatory T Cells Restrain Pathogenic Responses during Leishmania

amazonensis Infection.The J. of Immunology.174: 7147-7153.

JONES,D.E., L.U.Buxbaum, and P.Scott. 2000. IL-4-independent inhibition of

IL-12 responsiveness during Leishmania amazonensis infection. J.Immunol.

:364-372.

JONES,D.E., M.R.Ackermann, U.Wille, C.A.Hunter, and P.Scott. 2002. Early

enhanced Th1 response after Leishmania amazonensis infection of C57BL/6

Interleukin-10- deficient mice does not lead to resolution of infection.

Infect.Immun. 70:2151-2158.

KARUPIAH, G., Fredricson T.N., Holmes K.L., Khairallah, L.H., and Buller,

R.M. 1993. Importance of interferons in recovery from mousepox. J.Virol. 67(7):

-4226. 72

KRECKLER, L.M., Wan, T.C., Ge, Z.D. and Auchampach, J.A. 2005.

Adenosine inhibits tumor necrosis factor –alpha release from mouse peritoneal

macrophages via A2A and A2B but not the A3 adenosine

receptor.J.Pharmacol.Exp.Ther. 317; 172-180.

KIMA, P.E., S.L.Constant, L.Hannum, M.Colmenares, K.S.Lee, A.M.Haberman,

M.J.Shlomchick, and D.Macmahon-Pratt. 2000. Internalization of Leishmania

mexicana complex amastogotes via the Fc receptor is required to sustain

infection in murine cutaneous leishmaniasis. J.Exp.Med. 191:1063-1068.

KLEMPNER, M. S., M. Cedron, and D. J. Wyler. 1983. Attachment of plasma

vesicles of human macrophages to Leishmania tropica promastigotes.J. Infect.

Dis. 148~337.

KOPF, M., F.Brombacher, G.Köhler, G.Keinzle, K.-H.Widman, K.Lefrang,

C.Humborg, B.Lederman, and W.Solbach. 1996. IL-4-deficient BALB/c mice

resist infection with Leishmania major . J.Exp.Med. 184:1127-1136.

LA SALA,A., D.Ferrari, F.Di Virgilio, M.Idzko, J.Norgauer, and G.Girolomoni.

Alerting and tuning the immune response by extracellular nucleotides.

J.Leukoc.Biol. 73:339-343.

LAISON R. and Shaw JJ. 1987. Evolution, classification and geographical

distribution. In: Peters W, Killick-Kendrick R eds. The leishmaniasis in biology

and medicine. London: Academic Press, 1987:1– 1111.

LANGSTON, H.P., K. Yong, A.T. Gewirtz, K.E. Dombrowski, and J. A.

Kapp.2003.Secretion of IL-12 and IFN-γ, But IL-4, by Antigen-Specific T Cells

Requires Extracellular ATP. The Journal of Immunology. 170: 2962-2970.

LAPPAS, C.M., Rieger, J.M. and Linden, J.2005. A2A adenosine receptor

induction inhibitis IFN-gamma production in murine CD4+ Tcells. J. Immunol.

, 1073-1080.

LAUNOIS, P.; Maillard, I.; Pingel, S.; Swihart, K. G.; Xenarios I.; and AchaOrbea H..1997. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells

instruct Th2 development and susceptibility to Leishmania major in BALB/c

mice. Immunity, v.6, p.541-549,.

LEMOS, A.P., Souza, A.L.F., Pinheiro, A.A.S., Berrêdo-Pinho, M., and MeyerFernandes, J.R., 2002. Ecto-phosphatase activity on the cell surface of Crithidia

deanei. Zeitschrift für Natuforschung. 57c, 500–505.

LÉVESQUE SA, Lavoie EG, Lecka J, Bigonnesse F, and Sévigny J.Bigo. 2007.

Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse

ectonucleotidases. Br J Pharmacol.152(1):141-50.

LIEW, F.Y., S. Millott, C. Parkinson, R.M.J. Palmer, and S. Moncada. 1990.

Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide

from L-arginine. J. Immunol.144:4794-7. 73

LIEW, F.Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor-α synergizes with

IFN-γ, in mediating killing of Leishmania major through the induction of nitric

oxide. J.Immunol. 145:4306. LO, S.K.,Bovis, L., Matura, R. Zhu, B., Lum, H.,

Turco, S.J. and Ho, J.L.1998. Leishmania lipophosphoglycan reduces monocyte

transendothelial migration: modulation of cell adhesion molecules, intercellular

junctional proteins, andchemoattractants.J.Immulo.160.1857-1865

LOCKSLEY, R.M.; Heinzel, F.P.; Sadick, M.D.; Holaday, B.J.; and Gardner

K.D. Murine cutaneous leishmaniasis: susceptibility correlates with differencial

expansion of helper T-cell subsets. Annual Inst. Pasteur Immunology, v.138,

p.744-749, 1987.

LOOKER, D.L. Berens, R.L. and Marr, J.J. 1983.Purine metabolism in

Leishmania dono6ani amastigotes and promastigotes. Mol Biochem Parasitol

:15–28.

MALOY, K.J. and F.Powrie.2001.Regulatory T Cells in the control of immune

pathology. Nat. Immunol. 2, 816-819.

MAOILI, T.U., E.Takane, R.M.Arantes, J.L.Fietto, and L.C. Afonso. 2004.

Immune response induced by New World Leishmania species in C57BL/6 mice.

Parasitol.Res. 94:207-212. MARR, J.J.Berens, R.L., and Nelson, D.J.1978.

Purine metabolism and Leishmania donovani and Leishmania braziliensis.

Biochim.Biophys.Acta.544, 360-371.

MARCUS AJ, Broekman M.J., Drosopoulos J.H, Islam N, Pinsky DJ, Sesti C,

and Levi R 2003. Metabolic control of excessive extracellular nucleotide

accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular

diseases. J Pharmacol Exp Ther 305:9–16.

MARQUES-DA-SILVA, E.A. Oliveira, J.C. Figueiredo, A.B. Júnior, D.S.L.

Carneiro, C.M. Fietto, J.L.R. and Afonso L.C.C. 2008. Extracellular nucleotide

metabolism in Leishmania: influence of adenosinein the establishment of

infection. Microbes and infection. 850-857

MEYER-FERNANDES, J.R. 2002. Ecto-ATPases in protozoa prasites looking

for a function. Parasitol.Int. 51:299-303.

MEYER-FERNANDES, J.R, Dutra, P.M., Rogrigues, C.O., Saada-Nehme, J. and

Lopes, H.A. 1997. Mg-dependent ecto-ATPase activity in Leishmania Tropica.

Arch.Biochem.Biophys.341, 41-50.

MIZUMOTO N, Kumamoto T, Robson SC, Sevigny J, Matsue H,Enjyoji K,

Takashima A 2002.CD39 is the dominant Langerhans cell-associated ectoNTPDase: modulatory roles in inflammation and immune responsiveness. Nat

Med 8:358–365

MAHAUT-SMITH, M.P., Ennion, S.J. Rolf, M.G. and Evans, R.J.2000. ADP is

not an agonist at P2X(1) receptors evidence for separate receptors stimulated by

ATP and ADP on human platelets . Br. Pharmacol.. 131, 108-114. 74

MURRAY, H.W., J.D.Berman, C.R.Davies, and N.G.Saravia. 2005. Advances

and leishmaniases. Lancet. 366:1561-1577.

MURRAY HW, and Nathan CF. 1999.Macrophage microbicidal mechanisms in

vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular

visceral Leishmania donovani. Journal of Experimental. Medicine 189: 741-746,

NAKAAR, V. Beckers, C.J.M. Polotsky, V. and Joiner, K.A.1998. Basis for

substrate specificity of the Toxoplasma gondii nucleotide triphosphate hydrolase.

Mol Biochem Parasitol.97:209-20.

NEWMAN, C. 2003. Serum-free cell culture—the ethical, scientific and

economic choice. Biomed. Scientist.941–942.

NORTH, R.A. and Suprenant, A. 2000. Pharmacology of cloned P2X receptors.

Annu.Rev.Pharmacol.Toxicol. 40, 563-580.

PANTHER E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G,

and Norgauer J.2003. Adenosine affects expression of membrane molecules,

cytokine and chemokine release, and the T-cell stimulatory capacity of human

dendritic cells. Blood. 15;101(10):3985-90.

PEARSON, R.D., Wheeler, D.A., Harrison, L.H. and Kay, H.D. 1983. The

imunobiology of leishmaniasis. Rev. Infect. Dis. 5: 907

PINELLI E, Ellick-Kendrick R, and Wagenaar J.1994. Cellular and humoral

immune responses in dogs experimentally and naturally infected with

Leishmania infantum. Infect Immun 62:229–35.

PLESNER L. Ecto-ATPases: identities and functions. 1995.Int Rev

Cytol;158:141 –214.

POSNER, B.I., Faure, R., Burgess, J.W., Bevan, A.P., Lachance, D., Zhnag-Sun,

G., Fantus, I.G., Ng, J.B., Hall, D.A., Lum, B.S., Shaver, A., 1994.

Peroxovanadium compounds a new class of potent phosphotyrosine phosphatase

inhibitors which are insulin mimetics. Journal of Biological Chemistry. 269,

–4604.

RASKOVALOVA, T., Huang, X., Sitkovsky, M., Zacharia, L.C., Jackson, E.K.

and Gorelik, E.2005. Gs protein acoupled receptor signaling and lytic function of

activated NK cells. J.Immunol. 175, 4383-4391.

REITHINGER, R. and Dujardin, J.C. 2007. Molecular Diagnosis of

leishmaniasis: Current Status and Future Applications. J.Clin.Microbiol.45:21-

RIBEIRO, J.M., Katz, O., Pannel, L.K.Waitumbi, J. and Warburg A.1999.

Salivary glands of the sand fly Phlebotomus papatasi contain pharmacologically

active amounts of adenosine and 5’-AMP. J.Exp.Biol. 202, 1551-1559.

ROGERS, K.A.; Dekrey, G.K.; Mbow, M.L.; Gillespie, R.D.; Brodskyn, C.I.;

and Titus, R.G. 2002. Type 1 and type 2 responses to Leishmania major. FEMS

Microbiology Letters, v.209, p.1-7. 75

ROGERS, K.A. and Titus, R.G.2003. Immunomodulatory effects of Maxadilan

and Phlebotomus papatasi sand fly salivary gland lysates on human primary in

vitro immune responses. Parasite Immunol. 25, 127-134

SACKS, D.and Kamhawi, S. 2001. Molecular aspects of parasite-vector and

vector-host interactions in leishmaniasis. Annual Review of Microbiology, v.55,

p.453-483.

SACKS, D. and Noben-Trauth, N. 2002. The immunology and susceptibility and

resistance Leishmania major in mice. Nat.Rev.Immunol. 2:845-858.

SACKS, D. and Perkins, P.V.1984. Indetification of Infective Stage Leishmania

Promastigotes.Science.233: 1417-1419

SAKAGUCHI, S.2004.Naturally Arising CD4+ Regulatory T Cells for

Immunologic Self-Tolerance and Negative Control of Immune Responses. Annu.

Rev. Immunol. 22, 531.

SCHNURR, M., Toy, T., Stoitzner, P., Cameron, P., Shin, A., Beecroft, T.2003.

ATP gradients inhibit the migratory capacity of specific human dendritic cell

types: implications for P2Y11 receptor signaling. Blood. 98: 153-159

SCHNURR, M., Then, F., Galambos, P., Scholz, C., Siegmund, B., Endres, S.,

and Eigler, A. 2000.Extracellular ATP and TNF-alpha synergize in the activation

and maturation of human dendritic cells. J.Immunol. 147, 3149-3155.

SCOTT, P. 1991.IFN-γ modulates the early development of Th1 and Th2

responses in a murine model of cutaneous leishmaniasis. Journal of Immunology,

v.147, p.3149-3155.

SILVA, R. and D.L. Sacks, 1987. Metacyclogenesis Is a Major Determinat of

Leishmania Promastigote Virulence e Attenuation.Infection and Immunity. 126:

-2806

SKELTON, L., Cooper, M., Murphy, M., & Platt, A.2003. Human immature

monocyte-derived dendritic cells express the G protein-coupled receptor GPR105

(KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist,

uridine diphosphoglucose. J. Immunol 171(4), 1941–1949.

SOMERS, G. R., Hammet, F. M., Trute, L., Southey,M. C., & Venter, D. J.

Expression of the P2Y6 purinergic receptor in human T cells infiltrating

inflammatory bowel disease. Lab Invest. 78(11), 1375–1383.

SOONG,L., C.H.Chang, J.Sun, B.J.Longley, Jr., N.H.Ruddle, R.A.Flavell, and

D.McMahon-Pratt.1997. Role of CD4+ T cells in pathogenesis associated with

Leishmania amazonensis infection. J.Immunol. 158:5374-5383.

SPÄTH, G.F. and Beverkley, S.M.. 2001. A lipophosphoglycan- independent

method for isolation of infective leishmania metacyclic promastigotes by density

gradient centrifugation. Exp.Prasitol. 99:97-103. 76

STUEHR, D., and M.A. Marletta. 1985. Mammalian nitrite biosynthesis: mouse

macrophages produce nitrite and nitrate in response to Escherichia coli

lipopolysaccharide. Proa Natl. Acad.Sci. USA. 82:7738.

SURPRENANT, A., Rassendrein, F., Kawashima, E., North, R.A., and Buell,

G.,1996. The citolytic P2Z receptor for extracellular ATP identified as a P2X

receptor P2X7.Science.272, 735-738.

TASCA, T., Bonan, C.D., Carli, C.A., Battastini, A.M. and Sarkis, J.J.2003.

Characterization of an ecto-5’-nucleotidase (EC 3.1.3.5) activity in intact cells of

Trichomonas vaginalis. Exp.Parasitol. 105, 71-78

TAUSSKY, H.H. and Schorr, E. 1953. A microcolorimetric method for the

determination of inorganic phosphorus. J.Biol.Chem.202.675-685.

THOMPSON, L.F., Eltzchig, H.K., Ibla, J.C. Van de Wiele. C.J., Resta, R.,

Morote-Garcia, J.C., and Colgan, S.P.2004.Crucial role of ecto-5’-nucleotidase

(CD73) in vascular leakage during hypoxia. J.Exp.Med. 200,1395-1405.

TRINCHIERI G, and Gerosa F. Immunoregulation by interleukin-12.

Journal of Leukocyte Biology 59: 505-511.

VALDINEREZ, M., C.Lonardoni, M.Russo, and S.Jancar. 2000. Essential Role

of Platelet - Activiting Factor in Control of Leishmania (Leishmania)

amazonensis Infection. Infect.Immun. 68:6355-6361.

VESTER,B., K.Muller, W.Solbach, and T.Laskay. 1999. Early gene expression

of NK cell-activating chemokines in mice resistant to leishmania major.

Infect.Immun. 67:3155-3159.

WALTERS, L. L. 1993. Leishmania differentiation in natural and unnatural sand

fly hosts. J. Euk. Microbiol. 40:196-206

WALTERS, L. L., G. B. Modi, R. B. Tesh, and T. Burrage. 1987. Host-parasite

relationship of Leishmania mexicana Mexicana and Lutzomyia abonenci

(Diptera: Psychodidae). Am. J. Trop.Med. Hyg. 36:294-314

WEI, X.; Charles, I.G.; Smitch, A.; Ure, J.; Feng, G.; Huang, F.; Xu, D.; Muller,

W.; Moncada, S.; Liew, F.Y. Altered immune responses in mice lacking

inducible nitric oxide synthase. Nature, v.375, p.408-411, 1995.

WORLD HEALTH ORGANIZATION.

http://www.who.int/tdr/dw/leish2004.htm.

WILKIN, F., Duhant, X., Bruyns, C., Suarez-Huerta, N., Boeynaems, J.M., and

Robaye, B. 2001. The P2Y11 receptor mediates the ATP-induced maturation of

human monocyte-derived dendritic cells. J.Immunol. 166, 7172-7177. 77

WYLER, D.J.1982. In Vitro Parasite Monocyte Interactions in Human

Leishmaniasis. Evidence for an active role of the parasite in attachment.J.Clin.70,

-88.

ZIMMERMANN, H. 1992. 5’-nucleotidase: molecular structure and functional

aspects.Bichem. J.285 (Pt2), 345-365.

ZIMMERMANN, H.2000. Extracellular metabolism of ATP and other

nucleotides. Naunyn Schmiedebergs. Arch. Pharmacol. 392, 299-X

FEFB309/2013/06/Microbiologia_Basica.pdf